CBD (or Cannabidiol) is a natural plant substance found in hemp (or Cannabis Sativa L) and belongs to the Cannabinoid molecule family. Grown on all continents for millennia, hemp is one of the oldest wild and cultivated plants on the planet. Of the 100 Cannabinoids present in hemp, THC and CBD are the two most known molecules and also the most active on our organism. Unlike THC, CBD is not at all psychoactive (or psychotropic), i.e. the consumption of CBD does not produce any intoxicating or hovering effects, CBD is therefore not considered as a narcotic or toxic substance.

​

The human body has an endocannabinoid system that regulates some of our essential biological functions such as sleep, appetite, anxiety, mood or physical pain. Cannabidiol has the particularity of stimulating our CB1 and CB2 receptors connected to the nervous system. The consumption of CBD would allow our body to better regulate these primary biological functions. In France and Europe, we can now find CBD in a multitude of formats: Capsules, Capsules, Flowers, E-liquids (or Vap), Oils, Oil spray, Pure crystals, Cosmetics (creams, balms, gels, ...), but also drinks (fresh or infusions) or sweets (often called Gummies). There are also CBD oils and candies specially designed for pets (dogs, cats, rabbits, hamsters, horses) to help them fight anxiety, stress, improve peeling or reduce muscle pain.
 

CBD is an active molecule with many interesting properties for our metabolism, and is commonly used in different industries, such as cosmetics, food and medicine. Now, all over the world, scientists and doctors are very interested in the many properties of CBD in order to better understand the therapeutic potential of the molecule. WHO (World Health Organization) has already assigned him a long list of potential properties: Analgesic, Anti-inflammatory, Antioxidant, Antipsychotic, Antidepressant, decreased anxiety, Unloading, Nerve protection. (Source: WHO (2018). Critical Review Report on Cannabidiol (CBD). Expert Committee on Pharmacodependence. Fortieth meeting. Geneva, 4-7 June 2018).
 

According to various recent scientific studies (such as the 2018 WHO study), Cannabidiol or CBD would have many promising properties for medical research (reduction of pain, reduction of anxiety, reduction of risk of cancer, improvement of mood, support of the immune system, balance of metabolism, reduction of sleep disorders, reduction of depression, prevention of arthritis or treatment of certain skin diseases). These results deserve to be confirmed, and many researchers and laboratories continue to explore this molecule that is still unknown in France in order to better know it and exploit its properties.